Clinical Lab Scientist II CLS HCA Healthcare IncClinical Lab Scientist II CLSSan Jose, CA$65.90–$84.97 / hourAccording to established procedures and policies You will perform preventative maintenance on laboratory instrumentation, interpret results as to their accuracy, acceptability and critical limits and organize work to meet established deadlines and record all data obtained You will work actively and be cooperative with nursing and other hospital staff to ensure timely patient care as well as assist with regulatory compliance You will be responsible for training lab personnel and are expected to perform in-charge assignment in the absence of a manager What qualifications you will need:Valid California State Department of Health Services Clinical Laboratory Scientist License. Job Summary and QualificationsOur Clinical Lab Scientists (level II) perform clinical testing in one or more of the following areas: blood bank, chemistry, serology, hematology, urinalysis, coagulation, special chemistry, microbiology and manual tests.
Senior Clinical Research Associate Protagonist Therapeutics IncSenior Clinical Research AssociateNewark, CA$135,000–$150,000 / yearSupport study vendor management by performing key activities as delegated by study CTM, including but not limited to: Participate in evaluation of new vendors (CROs, labs, central readers, EDC, etc.) by drafting and/or reviewing RFPs, analyzing responses and drafting work orders for select vendors • Manage the day to day interactions with select study vendor(s), such as a central or specialty lab including developing training materials, lab manuals and acting as first point of contact for issue and query escalation and resolution. Part of the clinical study team and takes a lead on execution by performing key activities as delegated by the Clinical Study lead, including but not limited to: Develop and/or review key study operational documents (e.g., study reference manual, laboratory and pharmacy manuals, data management plan, query generation, monitoring plan; review site audit reports) •.
Clinical Lab Scientist 1 3rd Shift, Sun - Thurs Personalis IncClinical Lab Scientist 1 3rd Shift, Sun - ThursFremont, CA$56.25–$66 / hourOur products are designed to detect minimal residual disease (MRD) and recurrence at the earliest timepoints, enable selection of targeted therapies based on ultra-comprehensive genomic profiling, and enhance biomarker strategy for drug development. Our full-time regular positions also include an annual performance-based bonus (or a sales incentive plan) and long-term incentive units (equity) provided as part of our compensation package, in addition to a full range of medical, financial, and/or other benefits, dependent on the level and position offered.
NewClinical Nurse Coordinator Telemetry HCA Healthcare IncClinical Nurse Coordinator TelemetrySan Jose, CA$91.36–$137 / hourCurrent and active California RN license BCLS, ACLS, and NIHSS certifications required Minimum 2 years cardiac/telemetry clinical nursing experience in an acute care hospital required Charge/Relief Charge/Nursing leadership experience highly desirable Benefits Good Samaritan Hospital offers a total rewards package that supports the health, life, career and retirement of our colleagues. In collaboration with other members of the management team, the CNC directs, monitors, and evaluates nursing care in accordance with established policies/procedures, serves as a resource person for staff, and models a commitment to the organization's vision/mission/values to support an unparalleled patient experience and clinical outcomes that contribute to overall departmental performance.
Associate Director, Clinical Operations Revolution MedicinesAssociate Director, Clinical OperationsRedwood City, California$186,000–$233,000 / yearThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Proven experience working with investigators, external experts and regulatory agencies and oversight of Contract Research Organizations and third-party vendors including realigning with CRO partners when deliverables are at risk, negotiating solutions and leading After Action Reviews to share lessons learned.
Associate Director, Clinical Operations Revolution Medicines IncAssociate Director, Clinical OperationsRedwood City, CA$186,000–$233,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Proven experience working with investigators, external experts and regulatory agencies and oversight of Contract Research Organizations and third-party vendors including realigning with CRO partners when deliverables are at risk, negotiating solutions and leading After Action Reviews to share lessons learned.
Senior Director, Clinical Biomarker Operations Revolution MedicinesSenior Director, Clinical Biomarker OperationsRedwood City, California$244,000–$305,000 / yearThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Revolution Medicines is seeking a strategic and experienced leader to serve as Senior Director, Clinical Biomarker Operations, responsible for leading the operational execution of biomarker and companion diagnostic (CDx) strategies across early- and late-stage clinical development programs.
Executive Director, GCP QA (Good Clinical Practice, Quality Assurance) Revolution MedicinesExecutive Director, GCP QA (Good Clinical Practice, Quality Assurance)Redwood City, California$265,000–$331,000 / yearThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Minimum of 15 years of experience in the pharmaceutical or biotechnology industry, including at least 10 years in GCP QA or clinical quality leadership roles, with demonstrated experience leading and hosting regulatory inspections (e.g., FDA BIMO, EMA, MHRA, PMDA).
Executive Director, GCP QA Good Clinical Practice, Quality Assurance Revolution Medicines IncExecutive Director, GCP QA Good Clinical Practice, Quality AssuranceRedwood City, CA$265,000–$331,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Minimum of 15 years of experience in the pharmaceutical or biotechnology industry, including at least 10 years in GCP QA or clinical quality leadership roles, with demonstrated experience leading and hosting regulatory inspections (e.g., FDA BIMO, EMA, MHRA, PMDA).
Clinical Trials Manager Integrated Resources, IncClinical Trials ManagerFoster City, CaliforniaContractorClinical Trials ManagerIn partnership with CPMs, provides guidance and daily oversight for the successful management of all aspects of international clinical trials within designated program budgets and timelines. Provide input to program budget and timelines to ensure successful management of all aspects of international clinical trials.
Senior Director, Clinical Biomarker Operations Revolution Medicines IncSenior Director, Clinical Biomarker OperationsRedwood City, CA$244,000–$305,000 / yearThe Opportunity: Revolution Medicines is seeking a strategic and experienced leader to serve as Senior Director, Clinical Biomarker Operations, responsible for leading the operational execution of biomarker and companion diagnostic (CDx) strategies across early- and late-stage clinical development programs. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.
Associate Director, Clinical Biomarker Development Revolution MedicinesAssociate Director, Clinical Biomarker DevelopmentRedwood City, California$186,000–$233,000 / yearThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. The Associate Director in Clinical Biomarker Development team, within Translational Medicine will play a key role in the design, execution, and interpretation of clinical biomarker strategies across Revolution Medicine’s oncology pipeline.
Senior Clinical Operations Asset Director (Oncology) Genentech IncSenior Clinical Operations Asset Director (Oncology)South San Francisco, CA$215,000–$399,400 / yearThe Opportunity: As a Senior Clinical Operations Asset Director, you will provide strategic leadership across one or more development assets spanning solid tumors and hematologic malignancies, helping shape Disease Area strategy and the future of Clinical Operations. Our team provides strategic operational leadership that shapes development plans, drives execution excellence, and enables high-quality, efficient clinical trials.
Senior Clinical Operations Asset Director (Immunology, Neurology, Ophthalmology, and CVRM) Genentech IncSenior Clinical Operations Asset Director (Immunology, Neurology, Ophthalmology, and CVRM)South San Francisco, CA$215,000–$399,400 / yearThe Opportunity: As a Senior Clinical Operations Asset Director, you will provide strategic leadership across one or more development assets in Immunology, Neurology, Ophthalmology, and/or CVRM (Cardiovascular, Renal & Metabolism) while helping shape disease area strategy and the future of Clinical Operations. Our team provides strategic operational leadership that shapes development plans, drives execution excellence, and enables high-quality, efficient clinical trials.
Associate Director, Clinical Biomarker Development Revolution Medicines IncAssociate Director, Clinical Biomarker DevelopmentRedwood City, CA$186,000–$233,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. The Opportunity: The Associate Director in Clinical Biomarker Development team, within Translational Medicine will play a key role in the design, execution, and interpretation of clinical biomarker strategies across Revolution Medicine's oncology pipeline.
East Bay Urologist - Clinical Assistant Professor of Urology Stanford UniversityEast Bay Urologist - Clinical Assistant Professor of UrologyStanford, CA$372,000–$399,000 / yearRobust Surgical Practice: Perform state-of-art clinic-based procedures to complex surgeries with access to imaging, multidisciplinary support, and cutting-edge robotic technology including Da Vinci robotics access, and Aquablation access coming soon. The pay offered to the selected candidate will be determined based on factors including (but not limited to) the experience and qualifications of the selected candidate including equivalent years in rank, training, and field or discipline; internal equity; and external market pay for comparable jobs.
NewClinical Supervising Attorney Santa Clara UniversityClinical Supervising AttorneySanta Clara, CA$102,800–$105,884 / yearImplement a training protocol for all UAP volunteers, which will include modules on key topics such as cultural competency, language access, ethics, and economic barriers facing those experiencing homelessness, to promote empathy, respect, empowerment, and a holistic approach to client-centered lawyering. In collaboration with the Executive Director and UI: Lead the program, providing strategic guidance to maintain a robust UAP that significantly expands legal services for people experiencing homelessness in Santa Clara County and service learning opportunities for law students.
Cell and Gene Therapy Discovery Stage Project Manager Stanford UniversityCell and Gene Therapy Discovery Stage Project ManagerStanford, CA$120,038–$153,486 / yearAs part of the Stanford University Center for Definitive and Curative Medicine (CDCM), the Discovery Stage Project Manager provides comprehensive project support and management resources to Stanford Investigators specializing in stem cell and gene therapies. This involves the management of complex, multifaceted projects and oversight of all functional areas involved in delivery of various aspects of clinical programs/studies while meeting collaborators needs and adhering to the program guidelines.
Senior Clinical Program Manager, Clinical Operations Revolution MedicinesSenior Clinical Program Manager, Clinical OperationsRedwood City, CaliforniaThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Ability to analyze operational data, contribute with a mind on quality, timeliness and fiscal responsibility, make and drive decisions, multi-task, prioritize tasks, anticipate challenges, and execute on goals as a member of an interdisciplinary team.
Senior Clinical Program Manager, Clinical Operations Revolution Medicines IncSenior Clinical Program Manager, Clinical OperationsRedwood City, CA$164,000–$205,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Ability to analyze operational data, contribute with a mind on quality, timeliness and fiscal responsibility, make and drive decisions, multi-task, prioritize tasks, anticipate challenges, and execute on goals as a member of an interdisciplinary team.